Summary
The gangliosidoses comprise an-ever increasing number of biochemically and phenotypically variant diseases. In most of them an autosomal recessive inherited deficiency of a lysosomal hydrolase results in the fatal accumulation of glycolipids (predominantly in the nervous tissue) and of oligosaccharides.
The structure, substrate specificity, immunological properties of and genetic studies on the relevant glycosidases, ganglioside GM1 β-galactosidase and β-hexosaminidase isoenzymes, are reviewed in this paper. Contrary to general expectation, only a poor correlation is observed between the severity of the disease and residual activity of the defective enzyme when measured with synthetic or natural substrates in the presence of detergents. For the understanding of variant diseases and for their pre- and postnatal diagnosis, the necessity of studying the substrate specificity of normal and mutated enzymes under conditions similar to the in vivo situation, e.g., with natural substrates in the presence of appropriate activator proteins, is stressed. The possibility that detergents may have adverse affects on the substrate specificity of the enzymes is discussed for the β-hexosaminidases. The significance of activator proteins for the proper interaction of lipid substrates and watersoluble hydrolases is illustrated by the fatal glycolipid storage resulting from an activator protein deficiency in the AB variant of GM2-gangliosidosis. Recent somatic complementation studies have revealed the existence of a presumably post-translational modification factor necessary for the expression of ganglioside GM1 β-galactosidase activity. This factor is deficient in a group of variants of GM1-gangliosidosis. Among the possible reasons for the variability of enzyme activity levels in heterozygotes and patients, allelic mutations, formation of hybrid enzymes, and the existence of patients as compound heterozygotes are discussed. All these may result in the production of mutant enzymes with an altered specificity for a variety of natural substrates.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- Cer:
-
ceramide
- Gal:
-
D-galactose
- GalNAc:
-
2-acetamido-2-deoxy-D-galactopyranoside
- Glc:
-
D-glucose
- MUF:
-
4-methylumbelliferone
- MUF-β-Gal:
-
4-methylumbelliferyl-β-D-galactopyranoside
- MUF-β-GalNAc:
-
4-methylumbelliferyl-2-acetamido-2-deoxy-β-D-galactopyranoside
- MUF-β-GlcNAc:
-
4-methylumbelliferyl-2-acetamido-2-deoxy-β-D-glucopyranoside
- NeuAc:
-
N-acetylneuraminic acid
- PNP-β-Gal:
-
p-nitrophenyl-β-D-galactopyranoside.
References
Adachi, M., Schneck, L., Volk, B. W.: Progress in investigations of sphingolipidoses. Acta Neuropathol. (Berl.) 43, 1–18 (1978)
Andermann, E., Andermann, F., Carpenter, S., Karpati, G., Grimes, D., Wolfe, L. S.: Juvenile Tay-Sachs disease (late-onset GM2-gangliosidosis) in two Lebanese families. Clin. Res. 22, 738A (1974)
Andria, G., DelGiulice, C., Reuser, A. J. J.: Atypical expression of β-galactosidase deficiency in a child with Hurler-like features but without neurological abnormalities. Clin. Genet. 14, 16–23 (1978)
Atsumi, T., Miyatake, T., Ohbuyashi, T., Mizuno, Y., Yoshida, M.: A case of Ramsey-Hunt syndrome with membranous cytoplasmatic bodies-like structures and β-galactosidase deficiency. Proc. Annu. Meet. Jpn. Neurol. Soc. (1976)
Azzo, A. d', Hoogeveen, A., De Wit-Verbeek, H. A.: A rapid and simple microfractionation method for the analysis of hexosaminidase A and B activities in small numbers of cultured (amniotic fluid) cells. Clin. Chim. Acta 88, 1–7 (1978)
Bach, G., Suzuki, K.: Heterogeneity of human hepatic N-acetyl-β-d-hexosaminidase A activity toward natural glycosphingolipid substrates. J. Biol. Chem. 250, 1328–1332 (1975)
Baecque, C. M. de, Suzuki, K., Rapin, I., Johnson, A. B., Whethers, D. L., Suzuki, K.: GM2-gangliosidosis, AB variant. Clinico-pathological study of a case. Acta Neuropathol. (Berl.) 33, 207–226 (1975)
Baker, H. J., Lindsey, J. R.: Animal model of human disease: Feline GM1-gangliosidosis. Am. J. Pathol. 74, 649–652 (1974)
Baker, H. J., Jr., Lindsey, J. R., McKhann, G. M., Farrell, D. F.: Neuronal GM1-gangliosidosis in a Siamese cat with β-galactosidase deficiency. Science 174, 838–839 (1971)
Baker, H. J., Mole, J. A., Lindsey, J. R., Creel, R. M.: Animal models of human ganglioside storage diseases. Fed. Proc. 35, 1199–1201 (1976)
Bartholomew, W. R., Rattazzi, M. C.: Immunochemical characterization of human β-d-N-acetyl-hexosaminidase from normal individuals and patients with Tay-Sachs disease. Int. Arch. Allergy Appl. Immunol. 46, 512–524 (1974)
Bearpark, T., Stirling, J. L.: Clearance of human N-acetyl-β-hexosaminidases from rat circulation. Biochem. J. 168, 435–439 (1977)
Bearpark, T. M., Stirling, J. L.: A difference in the specificities of human liver N-acetyl-β-hexosaminidases A and B, detected by their activities towards glycosaminoglycan oligosaccharides. Biochem. J. 173, 997–1000 (1978)
Bearpark, T., Bouquelet, S., Fournet, B., Montreuil, J., Spik, G., Stirling, J., Strecker, G.: Activity of N-acetyl-β-d-hexosaminidases A and B from human liver towards various oligosaccharides and a glycopeptide core derived from glycoproteins. FEBS Lett. 84, 379–384 (1977)
Belfiore, F., Vecchio, L. L., Napoli, E., Borzi, V.: Increased β-N-acetylglucosaminidase activity in diabetes mellitus. Clin. Chem. 20, 1229–1230 (1974)
Ben-Yoseph, Y., Geiger, B., Arnon, R.: Antibody-mediated thermal stabilization of human hexosaminidases. Immunochemistry 12, 221–226 (1975)
Ben-Yoseph, Y., Shapira, E., Edelman, D., Burton, B. K., Nadler, H. L.: Purification and properties of neutral β-galactosidases from human liver. Arch. Biochem. Biophys. 184, 373–379 (1977)
Bernheimer, H.: Ganglioside im Liquor cerebrospinalis und Tay-Sachs'sche Erkrankung. Klin. Wochenschr. 46, 258–261 (1968)
Bernheimer, H., Karbe, E.: Morphologische und neurochemische Untersuchungen von 2 Formen der amaurotischen Idiotie des Hundes: Nachweis einer GM2-Gangliosidose. Acta Neuropathol. (Berl.) 16, 243–261 (1970)
Bernheimer, H., Seitelberger, F.: Über das Verhalten der Ganglioside im Gehirn bei 2 Fällen von spätinfantiler amaurotischer Idiotie. Wien. Klin. Wochenschr. 80, 163–164 (1968)
Bernheimer, H., Molzer, B., Deisenhammer, E.: Sandhoff disease: ganglioside GM2 and asialo-GM2 accumulation in the cerebrospinal fluid. J. Neurochem. 29, 351–353 (1977)
Berra, B., Brunngraber, E. G.: Neuropathological changes in brain glycoproteins. Biochem. Exp. Biol. 13, 31–40 (1977)
Beutler, E., Kuhl, W.: Subunit structure of human hexosaminidase verified:interconvertibility of hexosaminidase isozymes. Nature 258, 262–264 (1975)
Beutler, E., Kuhl, W., Comings, D.: Hexosaminidase isoenzyme in type 0 GM2-gangliosidosis (Sandhoff-Jatzkewitz disease). Am. J. Hum. Genet. 27, 628–638 (1975a)
Beutler, E., Villacorte, D., Kuhl, W., Guinto, E., Srivastava, S.: Nonenzymatic conversion of human hexosaminidase A. J. Lab. Clin. Med. 86, 195–203 (1975b)
Beutler, E., Yoshida, A., Kuhl, W., Lee, J. E. S.: The subunits of human hexosaminidase A. Biochem. J. 159, 541–543 (1976)
Blakemore, W. F.: GM1-gangliosidosis in a cat. J. Comp. Pathol. 82, 179–185 (1972)
Booth, C. W., Gerbie, A. B., Nadler, H. L.: Intrauterine detection of GM1 gangliosidosis, type 2. Pediatrics 52, 521–524 (1973)
Bootsma, D., Galjaard, H.: Heterogeneity in genetic diseases studied in cultured cells. In: Models for the study of inborn errors of metabolism, F. A. Hommes (ed.). Amsterdam: Excerpta Medica (in press, 1979)
Brady, R. O.: Sphingolipidoses. Annu. Rev. Biochem. 47, 687–713 (1978)
Brady, R. O., Pentchev, P. G., Gal, A. E.: Investigations in enzyme replacement therapy in lipid storage diseases. Fed. Proc. 34, 1310–1315 (1975)
Braidman, I., Carroll, M., Dance, N., Robinson, D., Poenaru, L., Weber, A., Dreyfus, J. C., Overdijk, B., Hooghwinkel, G. J. M.: Characterisation of human N-acetyl-β-hexosaminidase C. FEBS Lett. 41, 181–184 (1974a)
Braidman, I., Carroll, M., Dance, N., Robinson, D.: Separation and properties of human brain hexosaminidase C. Biochem. J. 143, 295–301 (1974b)
Brandt, S., Clausen, J., Diemer, N. H., Faurholt-Pedersen, V., Jensen, G. E., Lademann, A., Melchior, J. C.: Juvenile neurolipidosis of Bernheimer-Seitelberger's type. Acta Neurol. Scand. 56, 587–602 (1977)
Brett, E. M., Ellis, R. B., Haas, L., Ikonne, J. U., Lake, B. D., Patrick, A. D., Stephens, R.: Lateonset GM2-gangliosidosis. Clinical, pathological, and biochemical studies on eight patients. Arch. Dis. Child. 48, 775–785 (1973)
Brunngraber, E. G., Witting, L. A., Haberland, C., Brown, B.: Glycoproteins in Tay-Sachs disease: Isolation and carbohydrate composition of glycopeptides. Brain Res. 38, 151–162 (1972)
Brunngraber, E. G., Brown, B. D., Aro, A.: Glycoproteins in brain tissue of 0-variant of GM2-gangliosidosis. J. Neurochem. 22, 125–128 (1974)
Burton, B. K., Ben-Yoseph, Y., Nadler, H. L.: Lactosyl ceramidosis: deficient activity of neutral β-galactosidase in liver and cultivated fibroblasts? Clin. Chim. Acta 88, 483–493 (1978)
Buxton, P., Cumings, J. N., Ellis, R. B., Lake, B. D., Mair, W. G. P., Roberts, J. R., Young, E. P.: A case of GM2-gangliosidosis of late onset. J. Neurol. Neurosurg. Psychiatry 35, 685–692 (1972)
Cantz, M., Kresse, H.: Sandhoff disease: Defective glycosaminoglycan catabolism in cultured fibroblasts and its correction by β-N-acetylhexosaminidase. Eur. J. Biochem. 47, 581–590 (1974)
Carmody, P. J., Rattazzi, M. C.: Conversion of human hexosaminidase A to hexosaminidase ‘B’ by crude Vibrio cholerae neuraminidase preparations: Merthiolate is the active factor. Biochim. Biophys. Acta 371, 117–125 (1974)
Carroll, M.: Characterization of proteins structurally related to human N-acetyl-β-d-glucosaminidase. Biochem. J. 173, 191–196 (1978)
Carroll, M., Robinson, D.: Immunological properties of N-acetyl-β-d-glucosaminidase of normal human liver and of GM2-gangliosidosis liver. Biochem. J. 131, 91–96 (1973)
Carroll, M., Robinson, D.: A low-molecular-weight protein cross-reacting with human liver N-acetyl-β-d-glucosaminidase. Biochem. J. 137, 217–221 (1974)
Cheetham, P. S. J., Robinson, D., Blakemore, W. F.: Animal models for GM1-gangliosidosis. Biochem. Soc. Trans. 2, 1121–1124 (1974)
Cheetham, P. S. J., Dance, N. E., Robinson, D.: A benign deficiency of type B β-galactosidase in human liver. Clin. Chim. Acta 83, 67–74 (1978)
Chern, C. J., Beutler, E., Kuhl, W., Gilbert, F., Mellman, W. J., Croce, C. M.: Characterization of heteropolymeric hexosaminidase A in human x mouse hybrid cells. Proc. Natl. Acad. Sci. USA 73, 3637–3640 (1976)
Chern, C. J., Kennett, R., Engel, E., Mellman, W. J., Croce, C. M.: Assignment of the structural genes for the α subunit of hexosaminidase A, mannosephosphate isomerase, and pyruvate kinase to the region q22-qter of human chromosome 15. Somatic Cell Genetics 3, 553–560 (1977)
Christomanou, H., Cáp, C., Sandhoff, K.: Prenatal diagnosis of Tay-Sachs disease in cell-free amniotic fluid. Klin. Wochenschr. 56, 1133–1135 (1978)
Cohen, C. M., Weissmann, G., Hoffstein, S., Awasthi, Y. C., Srivastava, S. K.: Introduction of purified hexosaminidase A into Tay-Sachs leukocytes by means of immunoglobulin-coated liposomes. Biochemistry 15, 452–460 (1976)
Conzelmann, E., Sandhoff, K.: AB variant of infantile GM2-gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. Proc. Natl. Acad. Sci. USA 75, 3979–3983 (1978)
Conzelmann, E., Sandhoff, K., Nehrkorn, H., Geiger, B., Arnon, R.: Purification, biochemical and immunological characterisation of hexosaminidase A from variant AB of infantile GM2 gangliosidosis. Eur. J. Biochem. 84, 27–33 (1978)
Cork, L. C., Munnell, J. F., Lorenz, M. D., Murphy, J. V., Baker, H. J., Rattazzi, M. C.: GM2-ganglioside lysosomal storage disease in cats with β-hexosaminidase deficiency. Science 196, 1014–1017 (1977)
Cork, L. C., Munnell, J. F., Lorenz, M. D.: The pathology of feline GM2-gangliosidosis. Am. J. Pathol. 90, 723–734 (1978)
Desnick, R. J., Simmons, R. L., Allen, K. Y., Woods, J. E., Anderson, C. F., Najarian, J. S., Krivit, W.: Correction of enzymatic deficiencies by renal transplantation: Fabry's disease. Surgery 72, 203–211 (1972)
Desnick, R. J., Krivit, W., Sharp, H. L.: In utero diagnosis of Sandhoff's disease. Biochem. Biophys. Res. Commun. 51, 20–26 (1973a)
Desnick, S. J., Desnick, R. J., Brady, R. O., Pentchev, P. G., Simmons, R. L., Najarian, J. S., Swaiman, K., Sharp, H. L., Krivit, W.: Renal transplantation in type II Gaucher disease. Birth Defects 9, 109–119 (1973b)
Desnick, R. J., Thorpe, S. R., Fiddler, M. B.: Toward enzyme therapy for lysosomal storage diseases. Physiol. Rev. 56, 57–99 (1976)
Donnelly, W. J. C., Sheahan, B. J., Kelly, M.: Beta-galactosidase deficiency in GM1-gangliosidosis of Friesian calves. Res. Vet. Sci. 15, 139–141 (1973)
Dreyfus, J. C., Poenaru, L., Svennerholm, L.: Absence of hexosaminidase A and B in a normal adult. N. Engl. J. Med. 292, 61–63 (1975)
Dreyfus, J. C., Poenaru, L., Vibert, M., Ravise, N., Boue, J.: Characterization of a variant of β-hexosaminidase: ‘Hexosaminidase Paris’. Am. J. Hum. Genet. 29, 287–293 (1977)
Farrell, D. F., Baker, H. J., Herndon, R. M., Lindsey, J. R., McKhann, G. M.: Feline GM1-gangliosidosis: Biochemical and ultrastructural comparisons with the disease in man. J. Neuropathol. Exp. Neurol. 32, 1–18 (1973)
Felding, J., Hultberg, B.: An atypical form of Sandhoff's disease. Case report and biochemical studies. Neuropaediatrie 9, 74–83 (1978)
Fiddler, M. B., Thorpe, S. R., Desnick, R. J.: Enzyme therapy: in vivo administration of erythrocyte-entrapped β-glucuronidase. Am. J. Hum. Genet. 26, 30A (1974)
Figura, K. von: Secretion of β-hexosaminidase by cultured human skin fibroblasts. Kinetics, effect of temperature, cell density, serum concentration and pH. Exp. Cell Res. 111, 15–21 (1978)
Fischer, G., Jatzkewitz, H.: The activator of cerebroside sulphatase. Binding studies with enzyme and substrate demonstrating the detergent function of the activator protein. Biochim. Biophys. Acta 481, 561–572 (1977)
Fischer, G., Jatzkewitz, H.: The activator of cerebroside sulphatase. A model of the activation. Biochim. Biophys. Acta 528, 69–76 (1978)
Fluharty, A. L., Stevens, R. L., Kihara, H.: Cerebroside sulfate hydrolysis by fibroblasts from a parent with metachromatic leukodystrophy. J. Pediatr. 92, 782–784 (1978)
Friedland, J., Schneck, L., Saifer, A., Pourfar, M., Volk, B. W.: Identification of Tay-Sachs disease carriers by acrylamide gel electrophoresis. clin. Chim. Acta 28, 397–402 (1970)
Frost, R. G., Holmes, E. W., Norden, A. G. W., O'Brien, J. S.: Characterization of purified human liver acid β-d-galactosidasesA2 and A3. Biochem. J. 175, 181–188 (1978)
Galjaard, H., Hoogeveen, A., De Wit-Verbeek, H. A., Reuser, A. J. J., Kiejzer, W., Westerveld, A., Bootsma, D.: Tay-Sachs and Sandhoff's disease: Intergenic complementation after somatic cell hybridization. Exp. Cell Res. 87, 444–448 (1974a)
Galjaard, H., Reuser, A. J. J., Henkels-Dully, M. J., Hoogeveen, A., Keijzer, W., De Wit-Verbeek, H. A., Niermeijer, M. F.: Genetic heterogeneity and variation of lysosomal enzyme activities in cultured human cells. In: Enzyme therapy in lysosomal storage diseases, J. M. Tager, G. J. M. Hooghwinkel, W. T. Daems (eds.), pp. 35–51. Amsterdam: North-Holland (1974b)
Galjaard, H., Hoogeveen, A., Keijzer, W., De Wit-Verbeek, H. A., Reuser, A. J. J., Ho, W. M., Robinson, D.: Genetic heterogeneity in GM1-gangliosidosis. Nature 257, 60–62 (1975)
Galjaard, H., Hoogeveen, A., Van Der Veer, E., Kleyer, W. J.: Microtechniques in prenatal diagnosis of genetic disease: Present scope and future possibilities. In: Proceedings of the Fifth International Congress of Human Genetics (Mexico City, 1976). Amsterdam: Excerta Medica 1977
Gatt, S., Barenholz, Y.: Enzymes of complex lipid metabolim. Annu. Rev. Biochem. 42, 61–90 (1973)
Geiger, B., Arnon, R.: Chemical characterization and subunit structure of human N-acetyl-hexosaminidases A and B. Biochemistry 15, 3484–3492 (1976)
Geiger, B., Ben-Yoseph, Y., Arnon, R.: Purification of human hexosaminidases A and B by affinity chromatography. FEBS Lett. 45, 276–281 (1974)
Geiger, B., Navon, R., Ben-Yoseph, Y., Arnon, R.: Specific determination of N-acetyl-β-d-hexosaminidase isozymes A and B by radioimmunoassay and radial immunodiffusion. Eur. J. Biochem. 56, 311–318 (1975)
Geiger, B., Arnon, R., Sandhoff, K.: Immunochemical and biochemical investigation of hexosaminidase S. Am. J. Hum. Genet. 29, 508–522 (1977a)
Geiger, B., Specht, B. U. von, Arnon, R.: Stabilization of human β-d-N-acetylhexosaminidase A towards proteolytic inactivation by coupling it to poly-N-vinylpyrrolidone. Eur. J. Biochem. 73, 141–147 (1977b)
Geiger, B., Calef, E., Arnon, R.: Biochemical and immunochemical characterization of hexosaminidase P. Biochemistry 17, 1713–1717 (1978a)
Geiger, B., Navon, R., Arnon, R.: Hexosaminidase A in amniotic fluid of Tay-Sachs fetuses. Clin. Chem. 24, 1131–1133 (1978b)
George, D. L., Francke, U.: Regional mapping of human genes for hexosaminidase B and diphtheria toxin sensitivity on chromosome 5 using mouse x human hybrid cells. Somatic Cell Genetics 3, 629–638 (1977)
Gilbert, F., Kucherlapati, R., Creagan, R., Murnane, M. J., Darlington, G. J., Ruddle, F. H.: Tay-Sachs' and Sandhoff's disease: The assignment of genes for hexosaminidase A and B to individual human chromosomes. Proc. Natl. Acad. Sci. USA 72, 263–267 (1975).
Goldberg, M. F., Cotlier, E., Fichenscher, L. G., Kenyon, K., Enat, R., Borowsky, S. A.: Macular cherry-red spot, corneal clouding, and β-galactosidase deficiency. Arch. Intern. Med. 128, 387–398 (1971)
Goldberg, J. D., Truex, J. H., Desnick, R. J.: Tay-Sachs disease: an improved, fully automated method for heterozygote identification by tear β-hexosaminidase assay. Clin. Chim. Acta 77, 43–52 (1977)
Goldie, W. D., Holtzman, D., Suzuki, K.: Chronic hexosaminidase A and B deficiency. Ann. Neurol. 2, 156–158 (1977)
Gregoriadis, G.: Liposomes in biology and medicine. Nature 271, 112–113 (1978a)
Gregoriadis, G.: Liposomes in therapy of lysosomal storage diseases. Nature 275, 695–698 (1978b)
Halley, D. J. J., De, Wit-Verbeek, H. A., Reuser, A. J. J., Galjaard, H.: The distribution of hydrolytic enzyme activities in human fibroblast cultures and their intercellular transfer. Biochem. Biophys. Res. Commun. 82, 1176–1182 (1978)
Handa, S., Yamakawa, T.: Biochemical studies in cat and human gangliosidosis. J. Neurochem. 18, 1275–1280 (1971)
Hansson, H. A., Holmgren, J., Svennerholm, L.: Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Proc. Natl. Acad. Sci. USA 74, 3782–3786 (1977)
Harzer, K.: Inheritance of the enzyme deficiency in three neurolipidoses: variant 0 of Tay-Sachs disease (Sandhoff's disease), classic Tay-Sachs disease, and metachromatic leukodystrophy. Identification of the heterozygous carriers. Humangenetik 20, 1–12 (1973)
Harzer, K., Benz, H. U.: Gangliosidosen: In: Handbuch der inneren Medizin, Band VII/4: Fett-stoffwechsel, G. Schettler, H. Greten, D. Seidel (eds.), pp 613–643, Berlin-Heidelberg-New York: Springer 1976
Harzer, K., Recke, A. S.: Sulfatide-excreting heterozygous carrier of juvenile metachromatic Leukodystrophy or asymptomatic patient of adult metachromatic leukodystrophy. Humangenetik 29, 299–307 (1975)
Harzer, K., Sandhoff, K., Schall, H., Kollmann, F.: Enzymatische Untersuchungen in Blut von Überträgern einer Variante der Tay-Sachs'schen Erkrankung (Variante 0). Klin. Wochenschr. 49, 1189–1191 (1971)
Hechtman, P.: Characterization of an activating factor required for hydrolysis of GM2 ganglioside catalyzed by hexosaminidase A. Can. J. Biochem. 55, 315–324 (1977)
Hechtman, P., Le, Blanc, D.: Purification and properties of the hexosaminidase A-activating protein from human liver. Biochem. J. 167, 693–701 (1977)
Hers, H. G., Van, Hoff, F.: Lysosomes and storage diseases. New York: Academic Press 1973
Ho, M. W., O'Brien, J. S.: Stimulation of acid beta-galactosidase activity by chloride ions. Clin. Chim. Acta 30, 531–534 (1970)
Ho, M. W., O'Brien, J. S.: Gaucher's disease: deficiency of ‘acid’ β-glucosidase and reconstitution of enzyme activity in vitro. Proc. Natl. Acad. Sci. USA 68, 2810–2813 (1971)
Ho, M. W., Cheetham, P., Robinson, D.: Hydrolysis of GM1-ganglioside by human liver β-galactosidase isoenzymes. Biochem. J. 136, 351–359 (1973)
Ho, M. W., Norden, A. G. W., Alhadeff, J. A., O'Brien, J. S.: Glycosphingolipid hydrolases: properties and molecular genetics. Mol. Cell. Biochem. 17, 125–140 (1977)
Hoeksema, H. L., Reuser, A. J. J., Hoogeveen, A. T., Westerveld, A., Galjaard, H.: Characterization of residual hexosaminidase activity in Sandhoff's disease using man-Chinese hamster cell hybrids. Hum. Genet. 39, 315–319 (1977a)
Hoeksema, H. L., Reuser, A. J. J., Hoogeveen, A., Westerveld, A., Braidman, I., Robinson, D.: Characterization of β-d-N-acetylhexosaminidase isoenzymes in man-Chinese hamster somatic cell hybrids. Am. J. Hum. Genet. 29, 14–23 (1977b)
Hoeksema, H. L., Van Diggelen, O. P., Galjaard, H.: Intergenic complementation after fusion of fibroblasts from different patients with β-galactosidase deficiency. Biochim. Biophys. Acta (in press), (1979)
Holmes, E. W., O'Brien, J. S.: Feline GM1-gangliosidosis: Characterization of the residual liver acid β-galactosidase. Am. J. Hum. Genet. 30, 505–515 (1978)
Hösli, P.: Quantitative assays of enzyme activity in single cells: early prenatal diagnosis of genetic disorders. Clin. Chem. 23, 1476–1484 (1977)
Hooghwinkel, G. J. M., Veltkamp, W. A., Overdijk, B., Lisman, J. J. W.: Electrophoretic separation of β-N-acetylhexosaminidases of human and bovine brain and liver and of Tay-Sachs tissue. Hoppe Seylers Z. Physiol. Chem. 353, 839–841 (1972)
Hultberg, B.: N-Acetylhexosaminidase activities in Tay-Sachs disease. Lancet 1969 II, 1195-1195
Humbel, R., Collart, M.: Oligosaccharides in urine of patients with glycoprotein storage diseases. I. Rapid detection by thin layer chromatography. Clin. Chim. Acta 60, 143–145 (1975)
Ihler, G. M., Glew, R. H., Schnure, F. W.: Enzyme loading of erythrocytes. Proc. Natl. Acad. Sci. USA 70, 2663–2666 (1973)
Ikonne, J. U., Rattazzi, M. C., Desnick, R. J.: Characterization of hex S, the major residual β hexosaminidase activity in type 0 GM2 gangliosidosis (Sandhoff-Jatzkewitz disease). Am. J. Hum. Genet. 27, 639–650 (1975)
Iwamori, M., Nagai, Y.: Ganglioside-composition of brain in Tay-Sachs disease: Increased amounts of GD2 and N-acetyl-β-d-galactosaminyl GD1a ganglioside. Neurochem. R. 3, 670–671 (1978)
Iwamori, M., Nagai, Y.: Ganglioside-composition of brain in Tay-Sachs disease: Increased amounts of GD2 and N-acetyl-β-d-galactosaminyl GD1a ganglioside. J. Neurochem. (in press, 1979)
Jatzkewitz, H., Sandhoff, K.: On a biochemically special form of infantile amourotic idiocy. Biochim. Biophys. Acta 70, 354–356 (1963)
Jatzkewitz, H., Pilz, H., Sandhoff, K.: deQuantitative Bestimmungen von Gangliosiden und ihren neuraminsäurefreien Derivaten bei infantilen, juvenilen und adulten Formen der amaurotischen Idiotie und einer spätinfantilen biocheischen Sonderform. J. Neurochem. 12, 135–144 (1965)
Johnson, W. G., Chutorian, A. M.: Inheritance of a new form of hexosaminidase deficiency. Ann. Neurol. 2, 266–266 (1977)
Johnson, W. G., Chutorian, A. M.: Inheritance of the enzyme defect in a new hexosaminidase deficiency disease. Ann. Neurol. 4, 399–403 (1978)
Johnson, W. G., Chutorian, A., Miranda, A.: A new juvenile hexosaminidase deficiency disease presenting as cerebellar ataxia. Neurology 27, 1012–1018 (1977)
Jørgensen, L., Blacksted, T. W., Harkmark, W., Steen, J. A.: Niemann-Pick disease: report of a case with histochemical evidence of neural storage of acid glycolipids. Arch. Neuropathol. (Berl.) 4, 90–106 (1964)
Kaback, M. M.: Tay-Sachs disease: screening and prevention. Prog. Clin. Biol. Res. 18, 0000–0000 (1977)
Kaback, M. M., Zeiger, R. S.: Heterozygote detection in Tay-Sachs disease. A prototype community screening program for the prevention of recessive genetic disorders. Adv. Exp. Med. Biol. 19, 613–632 (1972)
Kaback, M. M., Hirsch, P., Roy, C., Greenwald, S., Kirk, M.: Gene frequncies for Tay-Sachs (TSD) and Sandhoff's disease (SD) in Jewish and non-Jewish populations. Pediatr. Res. 12, 452–452 (1978)
Kan, Y. W., Dozy, A. M.: Antenatal diagnosis of sickle-cell anaemia by DNA analysis of amniotic-fluid cells. Lancet 1978 II, 910–912
Kaplan, A., Achord, D. T., Sly, W. S.: Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. Proc. Natl. Acad. Sci. USA 74, 2026–2030 (1977)
Kelly, T. E., Reynolds, L. W., O'Brien, J. S.: Segregation within a family of two mutant alleles for hexosaminidase A. Clin. Genet. 9, 540–543 (1976)
Kihara, H., Porter, M. T., Fluharty, A. L.: Enzyme replacement in cultured fibroblasts from metachromatic leukodystrophy. Birth Defects 9, 19–26 (1973)
Kleijer, W. J., Niermeijer, M. F., Galjaard, H.: Enzyme studies on small numbers of cultured cells. (in press, 1979)
Klenk, E.: Beiträge zur Chemie der Lipidosen. I. Niemann-Pick'sche Krankheit und amaurotische Idiotie. Hoppe Seylers Z. Physiol. Chem. 262, 128–143 (1939/1940)
Klenk, E.: Über die Ganglioside, eine neure Gruppe von zuckerhaltigen Gehirnlipoiden. Hoppe Seylers Z. Physiol. Chem. 273, 76–86 (1942)
Kolodny, E. H.: Sandhoff's disease: studies on the enzyme defect in homozygotes and detection of heterozygotes. Adv. Exp. Med. Biol. 19, 321–341 (1972)
Kolodny, E. H., Mumford, R. A.: Human leucocyte acid hydrolases: characterization of eleven lysosomal hydrolases and study of reaction conditions for their automated analysis. Clin. Chim. Acta 70, 247–257 (1976)
Koster, J. F., Niermeijer, M. F., Loonen, M. C. B., Galjaard, H.: β-Galactosidase deficiency in an adult: a biochemical and somatic cell genetic study on a variant of GM1-gangliosidosis. Clin. Genet. 9, 427–432 (1976)
Krivit, W., Desnick, R. J., Lee, J., Moller, J., Wright, F., Sweeley, C. C., Snyder, P. D., Sharp, H. L.: Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. Am. J. Med. 52, 763–770 (1972)
Kudoh, T., Kikuchi, K., Nakamura, F., Yokoyama, S., Karube, K., Tsugawa, S., Minami, R., Nakao, T.: Prenatal diagnosis of GM1-gangliosidosis: biochemical manifestations in fetal tissues. Hum. Genet. 44, 287–293 (1978)
Kuhn, R., Wiegandt, H.: Die Konstitution der Ganglio-N-tetraose und des Gangliosids G1. Chem. Ber. 96, 866–880 (1963)
Lalley, P. A., Rattazzi, M. C., Shows, T. B.: Human β-d-N-acetylhexosaminidases A and B: expression and linkage relationships in somatic cell hybrids. Proc. Natl. Acad. Sci. USA 71, 1569–1573 (1974)
Landa, C. A., Maccioni, H. J. F., Arce, A. Caputto, R.: The biosynthesis of brain gangliosides. Separation of membranes with different ratios of ganglioside-sialylating activity to gangliosides. Biochem. J. 168, 325–332 (1977)
Lane, A. B., Jenkins, T.: Two variant hexosaminidase β-chain alleles segregating in a South African family. Clin. Chim. Acta 87, 219–228 (1978)
Ledeen, R. W.: Ganglioside structures and distribution: are they localized at the nerve ending? J. Supramol. Struct. 8, 1–17 (1978)
Ledeen, R. W., Salsman, K.: Structure of the Tay-Sachs' ganglioside. I. Biochemistry 4, 2225–2233 (1965)
Lee, J. E. S., Yoshida, A.: Purification and chemical characterization of human hexosaminidases A and B. Biochem. J. 159, 535–539 (1976)
Li, S.-C., Li, Y.-T.: An activator stimulating the enzymic hydrolysis of sphingoglycolipids. J. Biol. Chem. 251, 1159–1163 (1976)
Li, S. C., Wan, C. C., Mazzotta, M. Y., Li, Y. T.: Requirement of an activator for the hydrolysis of sphingoglycolipids by glycosidases of human liver. Carbohydr. Res. 34, 189–193 (1974)
Li, Y.-T., Mazzotta, M. Y., Wan, C.-C., Orth, R., Li, S.-C.: Hydrolysis of Tay-Sachs ganglioside by β-hexosaminidase A of human liver and urine. J. Biol. Chem. 248, 7512–7515 (1973)
Lowden, J. A.: Evidence for a hybrid hexosaminidase isoenzyme in heterozygotes for Sandhoff disease. Am. J. Hum. Genet. (in press, 1979)
Lowden, J. A., Callahan, J. W., Norman, M. G., Thain, M., Prichard, J. S.: Juvenile GM1-gangliosidosis. Arch. Neurol. 31, 200–203 (1974)
Lowden, J. A., Burton, R. M., Desnick, R. J., Goodman, S., Kaback, M. M., Kolodny, E. H., Rattazzi, M. C., Saifer, A.: Tay-Sachs carrier screening: a manual of methods. National Tay-Sachs and Allied Disease Association 1976
Lowden, J. A., Ives, E. J., Keene, D. L., Burton, A. L., Skomorowski, M. A., Howard, F.: Carrier detection in Sandhoff disease. Am. J. Hum. Genet. 30, 38–45 (1978)
Lundblad, A., Sjöblad, S., Svensson, S.: Characterization of a penta-and an octasaccharide from urine of a patient with juvenile GM1-gangliosidosis. Arch. Biochem. Biophys. 188, 130–136 (1978)
MacLeod, P. M., Wood, S., Jan, J. E., Applegarth, D. A., Dolman, C. L.: Progressive cerebellar ataxia, spasticity, psychomotor retardation, and hexosaminidase deficiency in a 10-year-old child: Juvenile Sandhoff disease. Neurology 27, 571–573 (1977)
Max, S. R., Maclaren, N. K., Brady, R. O., Bradley, R. M., Rennels, M. B., Tanaka, J., Garcia, J. H., Cornblath, M.: GM3 (hematoside) sphingolipodystrophy. N. Engl. J. Med. 291, 929–931 (1974)
Mehl, E., Jatzkewitz, H.: Eine Cerebrosidsulfatase aus Schweineniere. Hoppe Seylers Z. Physiol. Chem. 339, 260–276 (1964)
Meisler, M., Rattazzi, M. C.: Immunological studies of β-galactosidase in normal human liver and GM1 gangliosidosis. Am. J. Hum. Genet. 26, 683–691 (1974)
Miller, A. L., Frost, R. G., O'Brien, J. S.: Purification of human liver acid β-d-galactosidases using affinity chromatography. Analyt. Biochem. 74, 537–545 (1976)
Minauf, M.: Die sogenannten amaurotischen Idiotien. Stuttgart: Fischer 1975
Molzer, B., Bernheimer, H.: Detection of GM2-gangliosidosis (Tay-Sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay. Clin. Chim. Acta 73, 163–169 (1976)
Momoi, T., Sudo, M., Tanioka, K., Nakao, Y.: Tay-Sachs disease with altered β-hexosaminidase B: new variant? Pediatr. Res. 12, 77–81 (1978)
Mraz, W., Fischer, G., Jatzkewitz, H.: Low molecular weight proteins in secondary lysosomes as activators of different sphingolipid hydrolases. FEBS Lett. 67, 104–109 (1976)
Nakagawa, S., Kumin, S., Nitowsky, H. M.: Human hexosaminidase isozymes: chromatographic separation as an aid to heterozygote identification. Clin. Chim. Acta 75, 181–191 (1977)
Navon, R., Padeh, B.: Urinary test for identification of Tay-Sachs genotypes. J. Pediatr. 80, 1026–1029 (1972)
Navon, R., Padeh, B., Adam, A.: Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease. Am. J. Hum. Genet. 25, 287–293 (1973)
Navon, R., Geiger, B., Ben-Yoseph, Y., Rattazzi, M. C.: Low levels of β hexosaminidase A in healthy individuals with apparent deficiency of this enzyme. Am. J. Hum. Genet. 28, 339–349 (1976)
Neufeld, E. F., Lim, T. W., Shapiro, L. J.: Inherited disorders of lysosomal metabolism. Annu. Rev. Biochem. 44, 357–376 (1975)
Niermeijer, M. F., Fortuin, J. J. H., Koster, J. F., Jahodova, M., Galjaard, H.: Prenatal diagnosis of some lysosomal storage diseases. In: Enzyme therapy in lysosomal storage diseases, J. M. Tager, G. J. M. Hooghwinkel, W. T. Daems (eds.), pp. 25–33. Amsterdam: North-Holland 1974
Norden, A. G. W., O'Brien, J. S.: Ganglioside GM1 β-galactosidase: studies in human liver and brain. Arch. Biochem. Biophys. 159, 383–392 (1973)
Norden, A. G. W., O'Brien, J. S.: An electrophoretic variant of β-galactosidase with altered catalytic properties in a patient with GM1 gangliosidosis. Proc. Natl. Acad. Sci. USA 72, 240–244 (1975)
Norden, A. G. W., Tennant, L. L., O'Brien, J. S.: GM1 ganglioside β-galactosidase A. Purification and studies of the enzyme from human liver. J. Biol. Chem. 249, 7969–7976 (1974)
O'Brien, J. S.: Generalized gangliosidosis. J. Pediatr. 75, 167–186 (1969)
O'Brien, J. S.: GM1-gangliosidosis. In: The metabolic basis of inherited disease, J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson (eds.), pp. 639–662. New York: McGraw-Hill 1972
O'Brien, J. S.: Tay-Sachs' disease and juvenile GM2-gangliosidosis. In: Lysosomes and storage diseases, H. G. Hers, F. Van Hoof (eds.), pp. 323–344. New York-London: Academic Press 1973
O'Brien, J. S.: Molecular genetics of GM1 β-galactosidase. Clin. Genet. 8, 303–313 (1975)
O'Brien, J. S.: Ganglioside storage disease. Adv. Hum. Genet. 3, 39–98 (1977)
O'Brien, J. S.: The gangliosidoses. In: The metabolic basis of inherited disease, J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson (eds.), pp. 841–865. New York: McGraw-Hill 1978
O'Brien, J. S., Norden, A. G. W.: Nature of the mutation in adult β-galactosidase deficient patients. Am. J. Hum. Genet. 29, 184–190 (1977)
O'Brien, J. S., Okada, S., Chen, A., Fillerup, D. L.: Tay-Sachs disease: detection of heterozygotes and homozygotes by serum hexosaminidase assay. N. Engl. J. Med. 283, 15–20 (1970)
O'Brien, J. S., Okada, S., Fillerup, D. L., Veath, M. L., Adornato, B., Brenner, P. H., Leroy, J. G.: Tay-Sachs disease: prenatal diagnosis. Science 172, 61–64 (1971)
O'Brien, J. S., Ho, M. W., Veath, M. L., Wilson, J. F., Myers, G., Opitz, J. M., ZuRhein, G. M., Spranger, J. W., Hartman, H. A., Haneberg, B., Grosse, F. R.: Juvenile GM1-gangliosidosis: clinical, pathological, chemical, and enzymatic studies. Clin. Genet. 3, 411–434 (1972)
O'Brien, J. S., Gugler, E., Giedion, A., Wiessmann, U., Herschkowitz, N., Meier, C., Leroy, J.: Spondyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid β-galactosidase deficiency. Clin. Genet. 9, 495–504 (1976)
O'Brien, J. S., Norden, A. G. W., Miller, A. L., Frost, R. G., Kelly, T. E.: Ganglioside GM2 N-acetyl-β-d-galactosaminidase and asialo GM2 (GA2) N-acetyl-β-d-galactosaminidase; studies in human skin fibroblasts. Clin. Genet. 11, 171–183 (1977)
Okada, S., O'Brien, J. S.: Tay-Sachs disease: generalized absence of a beta-d-N-acetylhexosaminidase component. Science 165, 698–700 (1969)
Okada, S., Veath, M. L., O'Brien, J. S.: Juvenile GM2-gangliosidosis: partial deficiency of hexosaminidase A. J. Pediatr. 77, 1063–1065 (1970)
Okada, S., McCrea, M., O'Brien, J. S.: Sandhoff's disease (GM2 gangliosidosis type 2): clinical, chemical, and enzyme studies in five patients. Pediatr. Res. 6, 606–615 (1972)
O'Neill, B., Butler, A. B., Young, E., Falk, P. M., Bass, N. H.: Adult-onset GM2-gangliosidosis. Seizures, dementia, and normal pressure hydrocephalus associated with glycolipid storage in the brain and arachnoid granulation. Neurology 28, 1117–1123 (1978)
Orii, T., Minami, R., Sukegawa, K., Sato, S., Tsugava, S., Horino, K., Miura, R., Nakao, T.: A new type of mucolipidosis with β-galactosidase deficiency and glycopeptiduria. Tohoku J. Exp. Med. 107, 303–315 (1972)
Padeh, B., Navon, R.: Diagnosis of Tay-Sachs disease by hexosaminidase activity in leukocytes and amniotic fluid cells. Isr. J. Med. Sci. 7, 259–264 (1971)
Pentchev, P. G., Barranger, J. A.: Sphingolipidoses: molecular manifestations and biochemical strategies. J. Lipid Res. 19, 401–409 (1978)
Percy, A. K., Kaback, M. M., Herndon, R. M.: Metachromatic leukodystrophy: comparison of early-and late-onset forms. Neurology 27, 933–941 (1977)
Philippart, M., Franklin, S. S., Gordon, A.: Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation. Ann. Intern. Med. 77, 195–200 (1972)
Pierce, K. R., Kosanke, S. D., Bay, W. W., Bridges, C. H.: GM2 Gangliosidosis. Animal model: porcine cerebrospinal lipodystrophy (GM2 gangliosidosis). Am. J. Pathol. 83, 419–422 (1976)
Pilz, H., Sandhoff, K., Jatzkewitz, H.: Eine Gangliosidstoffwechselstörung mit Anhäufung von Ceramidlactosid, Monosialoceramidlactosid und Tay-Sachs-Gangliosid im Gehirn. J. Neurochem. 13, 1273–1282 (1966)
Pilz, H., Heipertz, R., Seidel, D.: Klinische, präklinische und pränatale Diagnose angeborener Sphingolipidosen durch Bestimmung lysosomaler Hydrolasen. Fortschr. Neurol. Psychiatr. 46, 207–221 (1978)
Pinsky, L., Miller, J., Shanfield, B., Watters, G., Wolfe, L. S.: GM1-Gangliosidosis in skin fibroblast culture: enzymatic differences between types 1 and 2 and observations on a third variant. Am. J. Hum. Genet. 26, 563–577 (1974)
Poenaru, L., Dreyfus, J. C.: Electrophoretic study of hexosaminidases. Hexosaminidase C. Clin. Chim. Acta 43, 439–442 (1973)
Poenaru, L., Weber, A., Vibert, M., Dreyfus, J. C.: Hexosaminidase C. Immunological distinction from hexosaminidase A. Biomedicine 19, 538–540 (1973)
Potier, M., Boire, G., Dallaire, L., Melancon, S. B.: N-acetyl-β-hexosaminidase isoenzymes of amniotic fluid and maternal serum. Their relevance to prenatal diagnosis of the GM2-gangliosidoses. Clin. Chim. Acta 76, 309–315 (1977)
Price, R. G., Dance, N.: The demonstration of multiple heat stable forms of N-acetyl-β-glucosaminidase in normal human serum. Biochim. Biophys. Acta 271, 145–153 (1972)
Purpura, D. P., Baker, H. J.: Neurite induction in mature cortical neurones in feline GM1-ganglioside storage disease. Nature 266, 553–554 (1976)
Purpura, D. P., Baker, H. J.: Meganeurites and other aberrant processes of neurones in feline GM1-gangliosidosis: a Golgi study. Brain Res. 143, 13–26 (1977)
Purpura, D. P., Pappas, G. D., Baker, H. J.: Fine structure of meganeurites and secondary growth processes in feline GM1-gangliosidosis. Brain Res. 143, 1–12 (1978)
Raghavan, S., Gajewski, A., Kolodny, E. H.: GM1-ganglioside β-galactosidase in leucocytes and cultured fibroblasts. Clin. Chim. Acta 81, 47–56 (1977)
Rapin, I., Suzuki, K., Suzuki, K., Valsamis, M. P.: Adult (chronic) GM2 gangliosidosis. Arch. Neurol. 33, 120–130, (1976)
Rattazzi, M. C., Brown, J. A., Davidson, R. G., Shows, T. B.: Tay-Sachs and Sandhoff-Jatzkewitz diseases: complementation of hexosaminidase A deficiency by somatic cell hybridization. Cytogenet. Cell Genet. 14, 232–235 (1975)
Rattazzi, M. C., Baker, H. A., Cork, L. C., Cox, N. R., Lanse, S. B., McCullough, R. A., Munnell, J. F.: The domestic cat as a model for human GM2 gangliosidosis: pathogenetic and therapeutic aspects. In: Models for the study of inborn errors of metabolism, F. A. Hommes (ed.). Amsterdam: Excerpta Medica (in press, 1979)
Read, D. H., Harrington, D. D., Keenan, T. W., Hinsman, E. J.: Neuronal-visceral GM1-gangliosidosis in a dog with β-galactosidase deficiency. Science 194, 442–445 (1976)
Reynolds, G. D., Baker, H. J., Reynolds, R. H.: Enzyme replacement using liposome carriers in feline GM1 gangliosidosis fibroblasts. Nature 275, 754–755 (1978)
Richardson, C. L., Keenan, T. W., Morre, D. J.: Ganglioside biosynthesis. Characterization of CMP-N-acetylneuraminic acid: lactosylceramide sialyltransferase in Golgi apparatus from rat liver. Biochim. Biophys. Acta 488, 88–96 (1977)
Robinson, D.: Carbohydrase deficiencies in storage diseases. Molecular Aspects of Medicine 2, 1–75 (1978)
Robinson, D., Stirling, J. L.: N-Acetyl-β-glucosaminidases in human spleen. Biochem. J. 107, 321–327 (1968)
Ropers, H. H., Grzeschik, K. H., Bühler, E.: Complementation after fusion of Sandhoff and TaySachs fibroblasts. Humangenetik 26, 117–121 (1975)
Rose, A. L., Pullarkat, R. K., Farmer, P. M., Mitra, N., Waran, S. P., Wisniewsky, K.: A new gangliosidosis with accumulation of GM3 ganglioside. Ann. Neurol. 2, 266–266 (1977)
Roseman, S.: The synthesis of complex carbohydrates by multiglycosyltransferase systems and their potential function in intercellular adhesion. Chem. Phys. Lipids 5, 270–297 (1970)
Rushton, A. R., Dawson, G.: Genetic linkage studies of the human glycosphingolipid β-galactosidases. Biochem. Genet. 15, 1071–1082 (1977)
Saifer, A., Parkhurst, G. W., Amoroso, J.: Automated differentiation and measurement of hexosaminidase isoenzymes in biological fluids and its application to pre-and postnatal detection of Tay-Sachs disease. Clin. Chem. 21, 334–342 (1975)
Saifer, A., Amoroso, J., Perle, G.: Urinary hexosaminidase analysis for the identification of Tay-Sachs genotypes. Clin. Chim. Acta 67, 315–319 (1976)
Sandhoff, K.: Auftrennung der Säuger-N-Acetyl-β-d-hexosaminidase in multiple Formen durch Elektrofokussierung. Hoppe Seylers Z. Physiol. Chem. 349, 1095–1098 (1968)
Sandhoff, K.: Variation of β-N-acetylhexosaminidase-pattern in Tay-Sachs disease. FEBS Lett. 4, 351–354 (1969)
Sandhoff, K.: Multiple human hexosaminidases. Birth Defects 9, 214–222 (1973)
Sandhoff, K.: The biochemistry of sphingolipid storage diseases. Angew. Chem. [Engl.] 16, 273–285 (1977)
Sandhoff, K., Harzer, K.: Total hexosaminidase deficiency in Tay-Sachs' disease (variant 0). In: Lysosomes and storage diseases, H. G. Hers, F. Van Hoof (eds.) pp. 345–356. New York: Academic Press (1973)
Sandhoff, K., Wässle, W.: Anreicherung und Charakterisierung zweier Formen der menschlichen N-Acetyl-β-d-hexosaminidase. Hoppe Seylers Z. Physiol. Chem. 352, 1119–1133 (1971)
Sandhoff, K., Andreae, U., Jatzkewitz, H.: Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs. Pathol. Eur. 3, 278–285 (1968)
Sandhoff, K., Harzer, K., Wässle, W., Jatzkewitz, H.: Enzyme alterations in lipid storage in three variants of Tay-Sachs disease. J. Neurochem. 18, 2469–2489 (1971)
Sandhoff, K., Conzelmann, E., Nehrkorn, H.: Specificity of human liver hexosaminidases A and B against glycosphingolipids GM2 and GA2. Purification of the enzymes by affinity chromatography employing specific elution. Hoppe Seylers Z. Physiol. Chem. 358, 779–787 (1977)
Schettler, G., Kahlke, W.: Gangliosidoses. In: Lipids and lipidoses, G. Schettler (ed.), pp. 213–259. Berlin-Heidelberg-New York: Springer 1967
Schneck, L., Friedland, J., Valenti, C., Adachi, M., Amsterdam, D., Volk, B. W.: Prenatal diagnosis of Tay-Sachs disease. Lancet 1970I, 582–583
Schneck, L., Adachi, M., Volk, B. W.: The fetal aspects of Tay-Sachs disease. Pediatrics 49, 342–351 (1972)
Schneck, L., Pinkett, B., Volk, B. W.: Asialo GM2-ganglioside in brain fetal Tay-Sachs disease. J. Neurochem. 24, 183–184 (1975)
Schram, A. W., Hamers, M. N., Samson, M. R., Cordus, S., de Jong, A., Brown, I., Robinson, D., Tager, J. M.: Factors affecting the hydrolysis of ceramide-3 by α-galactosidase A from human liver. Biochim. Biophys. Acta (in press, 1979)
Snyder, P. D. Jr., Wold, F., Bernlohr, R. W., Dullum, C., Desnick, R. J., Krivit, W., Condre, R. M.: Enzyme therapy. II. Purified human α-galactosidase A. Stabilization to heat and protease degradation by complexing with antibody and by chemical modification. Biochim. Biophys. Acta 350, 432–436 (1974)
Spence, M. W., Ripley, B. A., Embil, J. A., Tibbles, A. R.: A new variant of Sandhoff's disease. Pediatr. Res. 8, 628–637 (1974)
Spence, M. W., Welch, J. P., Burgen, J. K., MacKinnon, K. E., MacDonald, J. M., Clarke, J. T. R.: Studies of hexosaminidase activity in a normal adult male with absent serum hex A. Clin. Res. 25A, 692–692 (1977)
Srivastava, S. K., Ansari, N. H.: Altered α subunits in Tay-Sachs disease. Nature 273, 245–246 (1978)
Srivastava, S. K., Beutler, E.: Hexosaminidase A and hexosaminidase B: studies in Tay-Sachs' and Sandhoff's disease. Nature 241, 463–463 (1973)
Srivastava, S. K., Beutler, E.: Studies on human β-d-N-acetylhexosaminidases. III. Biochemical genetics of Tay-Sachs and Sandhoff's diseases. J. Biol. Chem. 249, 2054–2057 (1974)
Srivastava, S. K., Awasthi, Y. C., Yoshida, A., Beutler, E.: Studies on human β-d-N-acetylhexosaminidases. I. Purification and properties. J. Biol. Chem. 249, 2043–2048 (1974)
Stahl, P., Six, H., Rodman, J. S., Schlesinger, P., Tulsiani, D. R. P., Touster, O.: Evidence for specific recognition sites mediating clearance of lysosomal enzymes in vivo. Proc. Natl. Acad. Sci. USA 73, 4045–4049 (1976)
Stevenson, R. E., Taylor, H. A., Jr., Parks, S. E.: β-galactosidase deficiency: prolonged survival in three patients following early central nervous system deterioration. Clin. Genet. 13, 305–313 (1978)
Stirling, J. L.: A new form of N-acetyl-β-glucosaminidase present in pregnancy serum. Biochem. J. 123, 11P (1971)
Stirling, J. L.: Separation and characterization of N-acetyl-β-glucosaminidases A and P from maternal serum. Biochim. Biophys. Acta 271, 154–162 (1972)
Strecker, G., Herlant-Peers, M. C., Fournet, B., Montreuil, J.: Structure of seven oligosaccharides excreted in the urine of a patient with Sandhoff's disease (GM2-gangliosidosisvariant 0). Eur. J. Biochem. 81, 165–171 (1977)
Suzuki, K., Suzuki, Y.: Globoid cell leukodystrophy (Krabbe's disease): deficiency of galactocerebroside β-galactosidase. Proc. Natl. Acad. Sci. USA 66, 302–309 (1970)
Suzuki, K., Suzuki, K., Rapin, I., Suzuki, Y., Ishii, N.: Juvenile GM2-gangliosidosis. Clinical variant of Tay-Sachs disease or a new disease. Neurology 20, 190–204 (1970)
Suzuki, Y., Suzuki, K.: Partial deficiency of hexosaminidase component A in juvenile GM2-gangliosidosis. Neurology 20, 848–851 (1970)
Suzuki, Y., Suzuki, K.: Glycosphingolipid β-galactosidases. II. Electrofocusing characterization of the enzymes in human globoid cell leukodystrophy (Krabbe's disease). J. Biol. Chem. 249, 2105–2108 (1974a)
Suzuki, Y., Suzuki, K.: Glycosphingolipid β-galactosidases. IV. Electrofocusing characterization in GM1 gangliosidosis. J. Biol. Chem. 249, 2113–2117 (1974b)
Suzuki, Y., Koizumi, Y., Togari, H., Ogawa, Y.: Sandhoff disease: diagnosis of heterozygous carriers by serum hexosaminidase assay. Clin. Chim. Acta 48, 153–158 (1973)
Suzuki, Y., Nakamura, N., Fukuoka, K., Shimada, Y., Masanori, U.: β-Galactosidase deficiency in juvenile and adult patients. Report of six Japanese cases and review of literature. Hum. Genet. 36, 219–229 (1977)
Suzuki, Y., Nakamura, N., Fukuoka, K.: GM1-Gangliosidoses: accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types. Hum. Genet. 43, 127–131 (1978)
Svennerholm, L.: The chemical structure of normal human brain and Tay-Sachs ganglioside. Biochem. Biophys. Res. Commun. 9, 436–441 (1962)
Svennerholm, L.: Molecular neuropathology. Prog. Brain Res. 45, 101–122 (1976a)
Svennerholm, L.: Prenatal diagnosis of neurolipidoses. In: Prenatal diagnosis, A. Boué (ed.), pp. 141–153: Paris: Insern 1976b
Svennerholm, L.: Biochemical techniques for prenatal diagnosis of inherited metabolic diseases. (in press, 1979)
Tallman, J. F., Brady, R. O., Navon, R., Padeh, B.: Ganglioside catabolism in hexosaminidase A-deficient adults. Nature 252, 254–255 (1974a)
Tallman, J. F., Brady, R. O., Quirk, J. M., Villalba, M., Gal, A. E.: Isolation and relationship of human hexosaminidases. J. Biol. Chem. 249, 3489–3499 (1974b)
Tallman, J. F., Pentchev, P. G., Brady, R. O.: An enzymological approach to the lipidoses. Enzyme 18, 136–149 (1974c)
Tanaka, H., Suzuki, K.: Lactosylceramide β-galactosidase in human sphingolipidoses. Evidence for two genetically distinct enzymes. J. Biol. Chem. 250, 2324–2332 (1975)
Tanaka, J., Garcia, J. H., Max, S. R., Viloria, J. E., Kamijyo, Y., McLaren, N. K., Cornblath, M., Brady, R. O.: Cerebral sponginess and GM3 gangliosidosis: ultrastructure and probable pathogenesis. J. Neuropathol. Exp. Neurol. 34, 249–262 (1975)
Tay, W. A.: Symmetrical changes in the region of the yellow spot in each eye of an infant. Trans. Ophthalmol. Soc. UK 1, 55–57 (1881)
Terry, R. D., Weiss, M.: Studies in Tay-Sachs disease. II. Ultrastructure of the cerebrum. J. Neuropathol. Exp. Neurol. 22, 18–55 (1963)
Thomas, G. H.: β-d-Galactosidase in human urine, deficiency in generalized gangliosidosis. J. Lab. Clin. Med. 74, 725–731 (1969)
Thomas, G. H., Taylor, H. A., Miller, C. S., Axelman, J.: Migeon, B. R.: Genetic complementation after fusion of Tay-Sachs and Sandhoff cells. Nature 250, 580–582 (1974)
Thompson, J. N., Stoolmiller, A. C., Matalon, R., Dorfman, A.: N-Acetyl-β-hexosaminidase: role in the degradation of glycosaminoglycans. Science 181, 866–867 (1973)
Tomasi, L. G., Fukushima, D. K., Kolodny, E. H.: Steroid hexosaminidase activity in Tay-Sachs and Sandhoff-Jatzkewitz diseases. Neurology 24, 1158–1165 (1974)
Tsay, G. C., Dawson, G.: Oligosaccharide storage in brains from patients with fucosidosis, GM1-gangliosidosis and GM2-gangliosidosis (Sandhoff's disease). J. Neurochem. 27, 733–740 (1976)
Tsay, G. C., Dawson, G., Li, Y. T.: Structure of the glycopeptide storage material in GM1-gangliosidosis. Biochim. Biophys. Acta 385, 305–311 (1975)
Tsuboyama, A., Miki, F., Yoshida, M., Ogura, Y., Miyatake, T.: The use of tears for diagnosis of GM1 gangliosidosis. Clin. Chim. Acta 80, 237–242 (1977)
Ullrich, K., Mersman, G., Weber, E., Figura, K. von: Evidence for lysosomal enzyme recognition by human fibroblasts via a phosphorylated carbohydrate moiety. Biochem. J. 170, 643–650 (1978)
Vidgoff, J., Buist, N. R. M., O'Brien, J. S.: Absence of β-N-acetyl-d-hexosaminidase A activity in a healthy woman. Am. J. Hum. Genet. 25, 372–381 (1973)
Volk, B. W., Schneck, L.: The gangliosidosis. New York-London: Plenum Press 1975
Volk, B. W., Schneck, L.: Current trends in sphingolipidoses and allied disorders. New York-London: Plenum Press 1976
Wenger, D. A., Goodman, S. I., Myers, G. G.: Beta-galactosidase deficiency in young adults. Lancet 1974II, 1319–1320 (1974a)
Wenger, D. A., Sattler, M., Hiatt, W.: Globoid cell leukodystrophy: deficiency of lactosyl ceramide beta-galactosidase. Proc. Natl. Acad. Sci. USA 71, 854–857 (1974b)
Wenger, D. A., Tarby, T. J., Wharton, C.: Macular cherry-red spots and myoclonus with dementia: coexistent neuraminidase and β-galactosidase deficiencies. Biochem. Biophys. Res. Commun. 82, 589–595 (1978)
Werries, E., Neue, J., Buddecke, E.: Evidence for different glycohydrolase and glycosyltransferase activities of β-N-acetyl-hexosaminidases A and B. Hoppe Seylers Z. Physiol. Chem. 356, 953–960 (1975)
Witt, J. de, Hoeksema, H. L., Halley, D., Hagemeijer, A., Bootsma, D., Westerveld, A.: Regional localization of a β-galactosidase locus on human chromosome 22. Somatic Cell Genetics 3, 351–363 (1977)
Wit-Verbeek, H. A. de, Hoogeveen, A., Galjaard, H.: Complementation studies with enucleated fibroblasts from different variants of β-galactosidase deficiency. Exp. Cell Res. 113, 215–218 (1978)
Wolfe, L. S., Senior, R. G., Ng Ying Kin, N. M. K.: The structures of oligosaccharides accumulating in the liver of GM1-gangliosidosis, type I. J. Biol. Chem. 249, 1828–1838 (1974)
Wood, S.: Juvenile Sandhoff disease: complementation tests with Sandhoff and Tay-Sachs disease using polyethylene glycol-induced cell fusion. Hum. Genet. 41, 325–329 (1978)
Wood, S., MacDougall, B. G.: Juvenile Sandhoff disease: some properties of the residual hexosaminidase in cultured fibroblasts. Am. J. Hum. Genet. 28, 489–495 (1976)
Wyatt, P. R., Cox, D. M., Hoogstraten, J.: Tay-Sachs disease: ultrastructural studies on cultured fibroblasts. Pediatr. Res. 12, 310–313 (1978)
Yamakawa, T., Nagai, Y.: Glycolipids at the cell surface and their biological functions. Trends in Biological Sciences 3, 128–131 (1978)
Yamamoto, A., Adachi, S., Kawamura, S., Takahashi, M., Kitani, T., Ohtori, T., Shinji, Y., Nishikawa, M.: Localized β-galactosidase deficiency. Arch. Intern. Med. 134, 627–634 (1974)
Young, E. P., Ellis, R. B., Patrick, A. D.: Leucocyte β-galactosidase activity in GM1-gangliosidosis. Pediatrics 50, 502–509 (1972)
Zeman, W., Siakotos, A. N.: The neuronal ceroid-lipofuscinoses. In: Lysosomes and storage diseases, H. G. Hers, F. Van Hoff (eds.), pp. 519–551. New York: Academic Press 1973
Zerfowski, J., Sandhoff, K.: Juvenile GM2-Gangliosidose mit veränderter Substratspezifität der Hexosaminidase A. Acta Neuropathol. (Berl.) 27, 225–232 (1974)
Author information
Authors and Affiliations
Additional information
Variant B of infantile GM2-gangliosidosis, Tay-Sachs disease; Variant 0 of infantile GM2-gangliosidosis, Sandhoff disease, Sandhoff-Jatzkewitz disease; Variant 0 of juvenile GM2-gangliosidosis, juvenile Sandhoff disease; Variant AB, Variant AB of infantile GM2-gangliosidosis.
Rights and permissions
About this article
Cite this article
Sandhoff, K., Christomanou, H. Biochemistry and Genetics of gangliosidoses. Hum Genet 50, 107–143 (1979). https://doi.org/10.1007/BF00390234
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00390234